192 related articles for article (PubMed ID: 29803078)
21. Synthesis of sulfonamides incorporating piperazinyl-ureido moieties and their carbonic anhydrase I, II, IX and XII inhibitory activity.
Congiu C; Onnis V; Deplano A; Balboni G; Dedeoglu N; Supuran CT
Bioorg Med Chem Lett; 2015 Sep; 25(18):3850-3. PubMed ID: 26233435
[TBL] [Abstract][Full Text] [Related]
22. Synthesis of sulfonamides with effective inhibitory action against Porphyromonas gingivalis γ-carbonic anhydrase.
Ceruso M; Del Prete S; AlOthman Z; Osman SM; Scozzafava A; Capasso C; Supuran CT
Bioorg Med Chem Lett; 2014 Aug; 24(16):4006-10. PubMed ID: 25011913
[TBL] [Abstract][Full Text] [Related]
23. Synthesis and carbonic anhydrase inhibition of polycyclic imides incorporating N-benzenesulfonamide moieties.
Angeli A; Abdel-Aziz AA; Nocentini A; El-Azab AS; Gratteri P; Supuran CT
Bioorg Med Chem; 2017 Oct; 25(20):5373-5379. PubMed ID: 28789908
[TBL] [Abstract][Full Text] [Related]
24. Carbonic anhydrase inhibitors. Aromatic/heterocyclic sulfonamides incorporating phenacetyl, pyridylacetyl and thienylacetyl tails act as potent inhibitors of human mitochondrial isoforms VA and VB.
Güzel O; Innocenti A; Scozzafava A; Salman A; Supuran CT
Bioorg Med Chem; 2009 Jul; 17(14):4894-9. PubMed ID: 19539481
[TBL] [Abstract][Full Text] [Related]
25. Synthesis of novel acyl selenoureido benzensulfonamides as carbonic anhydrase I, II, VII and IX inhibitors.
Angeli A; Carta F; Bartolucci G; Supuran CT
Bioorg Med Chem; 2017 Jul; 25(13):3567-3573. PubMed ID: 28522267
[TBL] [Abstract][Full Text] [Related]
26. Benzenesulfonamide bearing 1,2,4-triazole scaffolds as potent inhibitors of tumor associated carbonic anhydrase isoforms hCA IX and hCA XII.
SitaRam ; Celik G; Khloya P; Vullo D; Supuran CT; Sharma PK
Bioorg Med Chem; 2014 Mar; 22(6):1873-82. PubMed ID: 24560737
[TBL] [Abstract][Full Text] [Related]
27. Seeking new approach for therapeutic treatment of cholera disease via inhibition of bacterial carbonic anhydrases: experimental and theoretical studies for sixteen benzenesulfonamide derivatives.
Gitto R; De Luca L; Mancuso F; Del Prete S; Vullo D; Supuran CT; Capasso C
J Enzyme Inhib Med Chem; 2019 Dec; 34(1):1186-1192. PubMed ID: 31282228
[TBL] [Abstract][Full Text] [Related]
28. Carbonic anhydrase inhibitors: Synthesis, molecular docking, cytotoxic and inhibition of the human carbonic anhydrase isoforms I, II, IX, XII with novel benzenesulfonamides incorporating pyrrole, pyrrolopyrimidine and fused pyrrolopyrimidine moieties.
Ghorab MM; Alsaid MS; Ceruso M; Nissan YM; Supuran CT
Bioorg Med Chem; 2014 Jul; 22(14):3684-95. PubMed ID: 24878360
[TBL] [Abstract][Full Text] [Related]
29. Synthesis of isoxazole-containing sulfonamides with potent carbonic anhydrase II and VII inhibitory properties.
Altug C; Güneş H; Nocentini A; Monti SM; Buonanno M; Supuran CT
Bioorg Med Chem; 2017 Feb; 25(4):1456-1464. PubMed ID: 28111158
[TBL] [Abstract][Full Text] [Related]
30. Anion inhibition profiles of the γ-carbonic anhydrase from the pathogenic bacterium Burkholderia pseudomallei responsible of melioidosis and highly drug resistant to common antibiotics.
Del Prete S; Vullo D; Di Fonzo P; Osman SM; AlOthman Z; Supuran CT; Capasso C
Bioorg Med Chem; 2017 Jan; 25(2):575-580. PubMed ID: 27914949
[TBL] [Abstract][Full Text] [Related]
31. Inhibition of α-, β- and γ-carbonic anhydrases from the pathogenic bacterium
Bonardi A; Nocentini A; Osman SM; Alasmary FA; Almutairi TM; Abdullah DS; Gratteri P; Supuran CT
J Enzyme Inhib Med Chem; 2021 Dec; 36(1):469-479. PubMed ID: 33472446
[TBL] [Abstract][Full Text] [Related]
32. New sulfonamides containing organometallic-acylhydrazones: synthesis, characterisation and biological evaluation as inhibitors of human carbonic anhydrases.
Huentupil Y; Peña L; Novoa N; Berrino E; Arancibia R; Supuran CT
J Enzyme Inhib Med Chem; 2019 Dec; 34(1):451-458. PubMed ID: 30734605
[TBL] [Abstract][Full Text] [Related]
33. Novel indolin-2-one-based sulfonamides as carbonic anhydrase inhibitors: Synthesis, in vitro biological evaluation against carbonic anhydrases isoforms I, II, IV and VII and molecular docking studies.
Eldehna WM; Al-Ansary GH; Bua S; Nocentini A; Gratteri P; Altoukhy A; Ghabbour H; Ahmed HY; Supuran CT
Eur J Med Chem; 2017 Feb; 127():521-530. PubMed ID: 28109946
[TBL] [Abstract][Full Text] [Related]
34. Flow synthesis and biological activity of aryl sulfonamides as selective carbonic anhydrase IX and XII inhibitors.
Rosatelli E; Carotti A; Ceruso M; Supuran CT; Gioiello A
Bioorg Med Chem Lett; 2014 Aug; 24(15):3422-5. PubMed ID: 24948563
[TBL] [Abstract][Full Text] [Related]
35. Coumarins effectively inhibit bacterial α-carbonic anhydrases.
Giovannuzzi S; Hewitt CS; Nocentini A; Capasso C; Flaherty DP; Supuran CT
J Enzyme Inhib Med Chem; 2022 Dec; 37(1):333-338. PubMed ID: 34979838
[TBL] [Abstract][Full Text] [Related]
36. Isoform-selective inhibitory profile of 2-imidazoline-substituted benzene sulfonamides against a panel of human carbonic anhydrases.
Supuran CT; Kalinin S; Tanç M; Sarnpitak P; Mujumdar P; Poulsen SA; Krasavin M
J Enzyme Inhib Med Chem; 2016; 31(sup1):197-202. PubMed ID: 27160030
[TBL] [Abstract][Full Text] [Related]
37. The γ-carbonic anhydrase from the pathogenic bacterium Vibrio cholerae is potently activated by amines and amino acids.
Angeli A; Del Prete S; Donald WA; Capasso C; Supuran CT
Bioorg Chem; 2018 Apr; 77():1-5. PubMed ID: 29316507
[TBL] [Abstract][Full Text] [Related]
38. Benzenesulfonamide derivatives as
Fantacuzzi M; D'Agostino I; Carradori S; Liguori F; Carta F; Agamennone M; Angeli A; Sannio F; Docquier JD; Capasso C; Supuran CT
J Enzyme Inhib Med Chem; 2023 Dec; 38(1):2201402. PubMed ID: 37073528
[No Abstract] [Full Text] [Related]
39. New series of sulfonamides containing amino acid moiety act as effective and selective inhibitors of tumor-associated carbonic anhydrase XII.
Ceruso M; Bragagni M; AlOthman Z; Osman SM; Supuran CT
J Enzyme Inhib Med Chem; 2015 Jun; 30(3):430-4. PubMed ID: 25089707
[TBL] [Abstract][Full Text] [Related]
40. Inhibition studies of bacterial α-carbonic anhydrases with phenols.
Giovannuzzi S; Hewitt CS; Nocentini A; Capasso C; Costantino G; Flaherty DP; Supuran CT
J Enzyme Inhib Med Chem; 2022 Dec; 37(1):666-671. PubMed ID: 35139743
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
